-
Product Insights
Coastal Plains Pekanbaru (CPP) PSC Field, Indonesia
Coastal Plains Pekanbaru (CPP) PSC upstream field is located in Riau, Indonesia. The upstream field is owned by PT Bumi Siak Pusako-Pertamina Hulu Indonesia. It is operated by PT Bumi Siak Pusako-Pertamina Hulu Indonesia. The project started its operations in 2001. Coastal Plains Pekanbaru (CPP) PSC Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start...
-
Product Insights
Dravacel – CPP Geothermal Power Plant 10 MW – Virovitick-Podravska
Equip yourself with the essential tools needed to make informed and profitable decisions with our Dravacel - CPP Geothermal Power Plant 10 MW - Virovitick-Podravska report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Arexpo/ CPP Inv/ Lendlease Italia – Milan Innovation District (MIND) Mixed-Use Development – Lombardy
Equip yourself with the essential tools needed to make informed and profitable decisions with our Arexpo/ CPP Inv/ Lendlease Italia - Milan Innovation District (MIND) Mixed-Use Development - Lombardy report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Eflornithine in Non-Small Cell Lung Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Eflornithine in Non-Small Cell Lung Cancer Drug Details: Eflornithine hydrochloride (CPP-1X) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Eflornithine in Gastric Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Eflornithine in Gastric Cancer Drug Details: Eflornithine hydrochloride (CPP-1X) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Eflornithine in Type 1 Diabetes (Juvenile Diabetes)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Eflornithine in Type 1 Diabetes (Juvenile Diabetes) Drug Details: Eflornithine hydrochloride (CPP-1X) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Eflornithine Hydrochloride + Sulindac) in Adenomas
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Eflornithine Hydrochloride + Sulindac) in AdenomasDrug Details: Eflornithine hydrochloride in fixed-dose combination with sulindac (TP-09, CPP-...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Eflornithine Hydrochloride + Sulindac) in Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.(Eflornithine Hydrochloride + Sulindac) in Colorectal Cancer Drug Details: Eflornithine hydrochloride in fixed-dose combination with sulindac...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VP-001 in Retinitis Pigmentosa (Retinitis)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. VP-001 in Retinitis Pigmentosa (Retinitis) Drug Details: VP-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AVLX-144 in Acute Ischemic Stroke
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AVLX-144 in Acute Ischemic Stroke Drug Details: AVLX-144 (UCCB-01144) is under development for the...
-
Sector Analysis
Czech Republic General Insurance Market Size and Trends by Line of Business, Distribution, Competitive Landscape and Forecast to 2027
Czech Republic General Insurance Market Overview The gross written premium of the Czech Republic general insurance market was CZK145.8 billion ($6.2 billion) in 2022 and is expected to achieve a CAGR of more than 7% during 2023-2027. The Czech economy is expected to slow down in 2023, which will be mainly due to high inflation and tight monetary conditions. To tackle inflation, the government has introduced various support measures that are expected to increase public expenditure. The Czech Republic general...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Leuprolide Acetate Sr in Kidney Disease (Nephropathy)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Leuprolide Acetate Sr in Kidney Disease (Nephropathy) Drug Details:Leuprolide acetate (Tapros, Tapros 3M Depot, Lupron Depot,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Leuprolide Acetate Sr in Liver Diseases
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Leuprolide Acetate Sr in Liver Diseases Drug Details:Leuprolide acetate (Tapros, Tapros 3M Depot, Lupron Depot, Lucrin...
-
Sector Analysis
Czech Republic Life Insurance Market Size and Trends by Line of Business, Distribution, Competitive Landscape and Forecast to 2027
Czech Republic Life Insurance Market Report Overview The gross written premium of the Czech Republic life insurance market was CZK54.3 billion ($2.3 billion) in 2022 and is expected to achieve a CAGR of more than 6% during 2023-2027. The Czech Republic life insurance market research report provides in-depth market analysis, information, insights, and a detailed outlook by product category for Czech Republic’s life insurance segment. It also provides values for key performance indicators such as gross written premium, penetration, and...
-
Company Profile
![]()
Shanghai Zijiang Enterprise Group Co Ltd – Company Profile
Shanghai Zijiang Enterprise Group Co Ltd (Shanghai Zijiang) is a provider of packaging solutions. Its product portfolio includes PET (polyethylene terephthalate) preforms, crown caps, plastic labels, sanitary packaging products, poly propylene (PP) closures, plastic printing products, biaxially-oriented polyethylene terephthalate (BoPET film), CPP film, PA film ink, paper printing products, and magnesium products. These products serve food and beverage, industrial, consumer and personal care markets. The company carries out scientific park construction and real estate activities. It operates through various subsidiaries...
Add to Basket -
Company Profile
![]()
Cosmo First Ltd – Company Profile
Cosmo First Ltd (Cosmo First ) is a provider of flexible packaging solutions. The company is involved in producing biaxially oriented polypropylene (BOPP) films and cast polypropylene (CPP) films. It offers a wide range of BOPP films including direct thermal printable films, velvet thermal lamination films, and high barrier films for flexible packaging, lamination, labeling, and industrial applications. The product portfolio of the company includes print and pouching films, overwrap films, wet (print) lamination films, dry (thermal) lamination films, pressure-sensitive...
Add to Basket -
Company Profile
![]()
Uflex Ltd – Company Profile
Uflex Ltd (Uflex) is a provider of flexible packaging solutions. It manufactures and markets flexible packaging products such as biaxially oriented polyethylene terephthalate (BOPET) films, biaxially oriented polypropylene (BOPP) films, cast polypropylene (CPP) films, and metalized films. The company also manufactures flexible laminates, pouches, bags, flexi -tubes and liquid packs, inks, adhesives, coatings, and polyols, and facilities for holography. It also develops packaging allied and printing machines including extrusion coating, aseptic liquid filling machines, and lamination machines. Uflex is also...
Add to Basket -
Product Insights
CPP Inv/ Lendlease Corp – The International Quarter Mixed-Use Community: Turing Building – Greater London
Equip yourself with the essential tools needed to make informed and profitable decisions with our CPP Inv/ Lendlease Corp - The International Quarter Mixed-Use Community: Turing Building - Greater London report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – eflornithine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry eflornithine Drug Details Eflornithine hydrochloride (CPP-1X) is under development for the treatment of non-small...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – AVLX-144
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AVLX-144 Drug Details AVLX-144 (UCCB-01144) is under development for the treatment of acute ischemic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.